Treatment for hepatitis B.
Cooke
Graham S
GS
Department of Infectious Diseases, St Mary's Campus, Imperial College London, London SW7 2AZ. g.cooke@imperial.ac.uk
Main
Janice
J
Thursz
Mark R
MR
D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D005260:Female; D005544:Forecasting; D015658:HIV Infections / Q000150:complications; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008099:Liver / Q000473:pathology; D018579:Patient Selection; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012307:Risk Factors
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents